Medicare confirms payment for prostate cancer drug (AP)
AP – Medicare officials confirmed Thursday that the program will cover the $93,000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease an extra four months to live. View full post on Yahoo! News: Health News
Filed in Uncategorized No Responses yet